Treatment-induced changes in ambulatory arterial stiffness index: One-year prospective study and meta-analysis of evidence

Hypertension Research

Volumn 38, Issue 9, 2015, Pages 627-631

  Kollias, Anastasios ^a   Rarra, Vayia ^a   Karpettas, Nikos ^a   Roussias, Leonidas ^a   O'Brien, Eoin ^b   Stergiou, George S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

ambulatory arterial stiffness index; ambulatory blood pressure monitoring; antihypertensive therapy; arterial compliance; drug treatment

Indexed keywords

AMLODIPINE; CARVEDILOL; HYDROCHLOROTHIAZIDE; IRBESARTAN; TELMISARTAN; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT;

ADULT; AMBULATORY ARTERIAL STIFFNESS INDEX; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL PARAMETERS; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; ELEVATED BLOOD PRESSURE; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIDDLE AGED; OSCILLOMETER; PROSPECTIVE STUDY; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ARTERIAL STIFFNESS; DRUG EFFECTS; HYPERTENSION; PATHOPHYSIOLOGY; PREDICTIVE VALUE; TREATMENT OUTCOME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84941065436     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.44     Document Type: Article

References (27)

1. Dolan E, Li Y, Thijs L, McCormack P, Staessen JA, O'Brien E, Stanton A. Ambulatory arterial stiffness index: rationale and methodology. Blood Press Monit 2006; 11: 103-105.
2. Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T, Stanton AV, Zhu DL, O'Brien E, Staessen JA. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension 2006; 47: 359-364.
3. Schillaci G, Parati G, Pirro M, Pucci G, Mannarino MR, Sperandini L, Mannarino E. Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension 2007; 49: 986-991.
4. Westerhof N, Lankhaar JW, Westerhof BE. Ambulatory arterial stiffness index is not a stiffness parameter but a ventriculo-arterial coupling factor. Hypertension 2007; 49: e7.
5. Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, O'Brien E, Staessen JA, Stanton AV. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006; 47: 365-370.
6. Hansen TW, Staessen JA, Torp-Pedersen C, Rasmussen S, Li Y, Dolan E, Thijs L, Wang JG, O'Brien E, Ibsen H, Jeppesen J. Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens 2006; 24: 2247-2253.
7. Kikuya M, Staessen JA, Ohkubo T, Thijs L, Metoki H, Asayama K, Obara T, Inoue R, Li Y, Dolan E, Hoshi H, Hashimoto J, Totsune K, Satoh H, Wang JG, O'Brien E, Imai Y. Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan. Stroke 2007; 38: 1161-1166.
8. Kollias A, Stergiou GS, Dolan E, O'Brien E. Ambulatory arterial stiffness index: a systematic review and meta-analysis. Atherosclerosis 2012; 224: 291-301.
9. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31: 1731-1768.
10. National Institute for Health and Clinical Excellence (NICE) Hypertension. The Clinical Management of Primary Hypertension in Adults. Clinical Guideline 127. 2011 http://www.nice.org.uk/guidance/CG127. Accessed 9 September 2014.
11. Andreadis EA, Sfakianakis ME, Tsourous GI, Georgiopoulos DX, Fragouli EG, Katsanou PM, Tavoularis EI, Skarlatou MG, Marakomichelakis GE, Ifanti GK, Diamantopoulos EJ. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness. Int Angiol 2010; 29: 266-272.
12. Andreadis EA, Angelopoulos ET, Kolyvas GN, Agaliotis GD, Mousoulis CG, Mousoulis GP. The effect of aliskiren versus ramipril-based treatment on the Ambulatory Arterial Stiffness Index in hypertensive patients. Int Angiol 2014; 33: 78-83.
13. Jin Y, Thijs L, Richart T, Li Y, Dolan E, Wang JG, Protogerou A, O'Brien E, Staessen JA, Safar ME. Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. Hypertens Res 2011; 34: 489-495.
14. Matsui Y, O'Rourke MF, Ishikawa J, Shimada K, Kario K. Association of changes in ambulatory arterial stiffness index and pulse wave velocity during antihypertensive treatment: the J-CORE study. Am J Hypertens 2012; 25: 862-868.
15. Stergiou GS, Karpettas N, Destounis A, Tzamouranis D, Nasothimiou E, Kollias A, Roussias L, Moyssakis I. Home blood pressure monitoring alone vs combined clinic and ambulatory measurements in following treatment-induced changes in blood pressure and organ damage. Am J Hypertens 2014; 27: 184-192.
16. Karpettas N, Destounis A, Kollias A, Nasothimiou E, Moyssakis I, Stergiou GS. Prediction of treatment-induced changes in target-organ damage using changes in clinic, home and ambulatory blood pressure. Hypertens Res 2014; 37: 543-547.
17. Gavish B, Ben-Dov IZ, Bursztyn M. Linear relationship between systolic and diastolic blood pressure monitored over 24 h: assessment and correlates. J Hypertens 2008; 26: 199-209.
18. Jekell A, Malmqvist K, Wallén NH, M?rtsell D, Kahan T. Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study. J Cardiovasc Pharmacol 2013; 62: 559-566.
19. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 The Cochrane Collaboration: Oxford, 2011.
20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
22. Litvin AY, Sukmarova ZN, Elfimova EM, Aksenova AV, Galitsin PV, Rogoza AN, Chazova IE. Effects of CPAP on 'vascular' risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag 2013; 9: 229-235.
23. Boesby L, Elung-Jensen T, Strandgaard S, Kamper AL. Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4-a randomized controlled study. PLoS One 2013; 8: e64549.
24. Ben-Dov IZ, Gavish B, Kark JD, Mekler J, Bursztyn M. A modified ambulatory arterial stiffness index is independently associated with all-cause mortality. J Hum Hypertens 2008; 22: 761-766.
25. Stergiou GS, Kollias A, Rarra VC, Roussias LG. Ambulatory arterial stiffness index: reproducibility of different definitions. Am J Hypertens 2010; 23: 129-134.
26. Ring M, Eriksson MJ, Zierath JR, Caidahl K. Arterial stiffness estimation in healthy subjects: a validation of oscillometric (Arteriograph) and tonometric (SphygmoCor) techniques. Hypertens Res 2014; 37: 999-1007.
27. Seidlerová J, Filipovský J, Mayer O, Wohlfahrt P, Cífková R. Positive effects of antihypertensive treatment on aortic stiffness in the general population. Hypertens Res 2014; 37: 64-68.